+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ovarian"

From
From
Ovarian Cancer - Pipeline Insight, 2023 - Product Thumbnail Image

Ovarian Cancer - Pipeline Insight, 2023

  • Clinical Trials
  • May 2023
  • 250 Pages
  • Global
From
Ovarian Cancer: Update Bulletin - Product Thumbnail Image

Ovarian Cancer: Update Bulletin

  • Newsletter
  • March 2024
  • Global
From
Gynecological Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Gynecological Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Infertility Treatment Global Market Report 2024 - Product Thumbnail Image

Infertility Treatment Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Vulvodynia Treatment Global Market Report 2024 - Product Thumbnail Image

Vulvodynia Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Gynecological Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Gynecological Cancer Drugs - Global Strategic Business Report

  • Report
  • March 2024
  • 193 Pages
  • Global
From
From
Loading Indicator

The Ovarian market is a segment of the Women's Health industry that focuses on the diagnosis, treatment, and prevention of ovarian diseases. It includes products and services related to the diagnosis, treatment, and prevention of ovarian cancer, ovarian cysts, and other ovarian disorders. The market also includes products and services related to fertility, contraception, and hormone replacement therapy. The Ovarian market is driven by the increasing prevalence of ovarian diseases, the growing awareness of the importance of early diagnosis and treatment, and the increasing demand for fertility treatments. Additionally, the development of new technologies and treatments for ovarian diseases is expected to drive the market growth. Some companies in the Ovarian market include AbbVie, AstraZeneca, Bayer, Merck, Novartis, Pfizer, and Roche. Show Less Read more